Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 In continuation to our letter dated July 31, 2019, we wish to inform you that the 19th Annual General Meeting ('AGM') of the Company was held today, August 24, 2019, and all the items of business mentioned in the Notice dated May 18, 2019 , were transacted. In this regard, please find enclosed the Summary of proceedings as required under Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records.
24-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Anand Velumani, Director, Nueclear Healthcare Limited, our wholly owned subsidiary, would be participating at the '15th Annual Global Investor Conference' organized by M/s. Motilal Oswal Financial Services Limited, at Hotel Grand Hyatt, Mumbai on 20th August, 2019, where representatives of various fund houses would be meeting him.
17-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company's financial results for Quarter ended June 30, 2019, on Wednesday, August 14, 2019 at 11.00 A.M. local time. Dr. A. Velumani, Chairman, Managing Director & CEO, Mr. A. Sundararaju, Executive Director & CFO, Mr. Sachin Salvi, Vice-President- Finance, and Dr. Caesar Sengupta, Vice President- Operations, will represent the Company. Dial-in details are given in the copy of enclosed Invite of M/s. Prabhudas Lilladher, who is organizing the con-call.
12-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

 We are forwarding copy of Presentation on Quarterly Results of our company for the quarter ended 30-06-2019. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.
12-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Results- Financial Results For The Quarter Ended June 30, 2019.

 The Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and consolidated) for the Quarter ended June 30, 2019. The Stand-alone and Consolidated unaudited financial results for the quarter ended June 30, 2019, along with the Limited Review Reports, are attached pursuant to Regulation 33 (3) (a) to (c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board has also approved issue and allotment of new equity shares not exceeding 37,859 shares to those employees who may be exercising the Stock Options granted to them in 2016 and vesting on them on 12th September 2019, subject to compliance with applicable regulations. Further we hereby declare that the statutory auditors have issued unmodified opinion on both the Stand-alone and Consolidated Financial Results. Please note that the meeting commenced at 17.00 hours and ended at 19.30 hours today, the 10th August, 2019.
10-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Outcome of Board Meeting

 The Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and consolidated) for the Quarter ended June 30, 2019. The Stand-alone and Consolidated unaudited financial results for the quarter ended June 30, 2019, along with the Limited Review Reports, are attached pursuant to Regulation 33 (3) (a) to (c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board has also approved issue and allotment of new equity shares not exceeding 37,859 shares to those employees who may be exercising the Stock Options granted to them in 2016 and vesting on them on 12th September 2019, subject to compliance with applicable regulations. Further we hereby declare that the statutory auditors have issued unmodified opinion on both the Stand-alone and Consolidated Financial Results. Please note that the meeting commenced at 17.00 hours and ended at 19.30 hours today, the 10th August, 2019.
10-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2019.

 Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Saturday, August 10, 2019, at the Corporate Office of the Company, inter alia, to consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter ended June 30, 2019. Intimation of the above meeting of the Board of Directors is also being published in newspapers, as required under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
02-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 As required under the provisions of Companies Act, 2013 and the rules made thereunder and the provisions of Regulations 44 & 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have released an advertisement about the 19th Annual General Meeting convened to be held at 3.00 P.M. on August 24, 2019, despatch of AGM Notice, Book Closure dates for payment of dividend on approval by shareholders and E-Voting facility made available to the shareholders to cast their votes through electronic mode. We are submitting herewith copies of the above newspaper advertisements published in The Free Press Journal (English) and The Pudhari (Marathi) on August 02, 2019.
02-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Corporate Action - Book Closure For AGM & Dividend

 As intimated to you separately, the 19th Annual General Meeting of the Company will be held on Saturday, 24th August 2019. In this regard, the Register of Member and Share Transfer Books of the Company will remain closed from Sunday, 18th August, 2019 to Saturday, 24th August, 2019 (both days inclusive) to determine the eligibility of Members for payment of dividend of Rs. 20/- per share, recommended by the Board of Directors, which, on approval by the Members, will be paid to those Members whose names appear on the Register of Members as on 17th August 2019.
31-07-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Reg. 34 (1) Annual Report

 This is to inform you that the 19th Annual General Meeting of the Company will be held at 03.00 P.M. on Saturday, August 24, 2019, at Hotel Yogi Midtown, Plot No. DX-12, TTC Industrial Area, Mumbai-Pune Road, Turbhe, Navi Mumbai-400 705 to transact the ordinary and special business set out in the Notice of the meeting. In this regard, pursuant to the Regulation 34(1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are submitting herewith a copy of the Annual Report along with the notice of the 19th Annual General Meeting, which is being sent to the Shareholders.
31-07-2019
Next Page
Close

Let's Open Free Demat Account